Boston Scientific Boston Scientific Corporation (BSC) is a company that develops, manufactures, and markets medical devices. | ![]() Cardiovascular Systems Cardiovascular Systems, Inc. (CSI) is a medical technology company that develops solutions for the revascularization of patients with complex coronary and peripheral artery disease (PAD). | |||||
Founding Date | Founding Date 1984 | Founding Date 1949 | Founding Date 1979 | Founding Date 1989 | Founding Date 1963 | Founding Date 1963 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Subsidiary | Type Subsidiary |
Tags | ||||||
Locations | Locations Colorado Springs, US HQ Bagsværd, DK Suresnes, FR Leusden, NL | Locations Galway, IE HQ Buenos Aires, AR Macquarie Park, AU Wien, AT Dhaka, BD Jette, BE Monções, BR see more | Locations Marlborough, US HQ Andar, BR Contagem, BR Ottawa, CA Shanghai, CN Coyol, CR La Aurora, CR see more | Locations Saint Paul, US HQ | Locations Berlin, DE HQ Buenos Aires, AR Buenos Aires, AR Pymble, AU Wien, AT Vilvoorde, BE São Paulo, BR see more | Locations Bloomington, US HQ Brisbane, AU Shanghai, CN Hong Kong, HK Chennai, IN Limerick, IE Tokyo, JP see more |
Employees | Employees 2746% decrease | Employees 95,000 | Employees 53,00010% increase | Employees 7257% decrease | Employees 2,370 | Employees 7,8261% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 114.6 b | Valuation ($) 124.5 b | Valuation ($) 844 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | ||||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $33.5b (FY, 2025) | Revenue (est.) $20.1b (FY, 2025) | Revenue (est.) $236.2m (FY, 2022) | Revenue (est.) €808.2m (FY, 2022) | Revenue (est.) $2.3b (FY, 2023) |
Cost of goods | Cost of goods N/A | Cost of goods $11.6b (FY, 2025) | Cost of goods $6.2b (FY, 2025) | Cost of goods $63.4m (FY, 2022) | Cost of goods €357.1m (FY, 2022) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $21.9b (FY, 2025) | Gross profit $13.9b (FY, 2025) | Gross profit $172.8m (FY, 2022) | Gross profit €451.1m (FY, 2022) | Gross profit N/A |
Net income | Net income N/A | Net income $4.7b (FY, 2025) | Net income $2.9b (FY, 2025) | Net income ($36.9m) (FY, 2022) | Net income (€36.8m) (FY, 2022) | Net income N/A |
Operating ⚠ | ||||||
Countries | Countries N/A | Countries 150 (FY, 2025) | Countries 130 (FY, 2022) | Countries N/A | Countries N/A | Countries N/A |
Funding | ||||||
Total funding raised | Total funding raised N/A | Total funding raised $ 340.8m | Total funding raised $ 2b | Total funding raised $ 69m | Total funding raised N/A | Total funding raised N/A |

Medtronic is a company that specializes in healthcare technologies and therapies.
View companyBoston Scientific Corporation (BSC) is a company that develops, manufactures, and markets medical devices.
View company
Cardiovascular Systems, Inc. (CSI) is a medical technology company that develops solutions for the revascularization of patients with complex coronary and peripheral artery disease (PAD).
View company
BIOTRONIK is a medical technology company that provides a range of products and services.
View company